# Local Dexamethasone Administration in Symptomatic Irreversible Pulpitis

> **NCT07672873** · NA · RECRUITING · sponsor: **Marmara University** · enrollment: 84 (estimated)

## Conditions studied

- Symptomatic Irreversible Pulpitis (SIP)
- Dental Pain

## Interventions

- **DRUG:** Saline (0.9%, sterile, for infusion)
- **DRUG:** Dexamethasone
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT07672873
- **Lead sponsor:** Marmara University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2026-12-15
- **Final completion:** 2026-12-18
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672873, "Local Dexamethasone Administration in Symptomatic Irreversible Pulpitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07672873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*